MARC details
| 000 -LEADER |
| fixed length control field |
04049ntm a2200325 i 4500 |
| 001 - CONTROL NUMBER |
| control field |
12102116 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
| control field |
20211024132559.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
| fixed length control field |
150118s2021 ua d f bm 000 0 eng | |
| 040 ## - CATALOGING SOURCE |
| Original cataloging agency |
EG-EULC |
| Transcribing agency |
EG-EULC |
| Description conventions |
rda |
| 041 0# - LANGUAGE CODE |
| Language code of text/sound track or separate title |
eng |
| Language code of summary or abstract/overprinted title or subtitle |
ara |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
| Classification number |
547.43 |
| Item number |
H.M.A |
| Edition number |
22 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
| Personal name |
Hassan, Mona Nabil Mohamed |
| 9 (RLIN) |
33880 |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
| Title |
Analytical study of some drugs containing Carbonyl group / |
| Statement of responsibility, etc |
Mona Nabil Mohamed Hassan, (B. Pharm. Sci., Future University in Egypt, 2013, Teaching Assistant in Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Sciences &Pharmaceutical Industries, Future University in Egypt ), supervision of Prof. Dr. Samah Sayed Abbas, (Professor and Head of Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University), Prof. Dr. Amr Mohamed Badawey, (Professor of Analytical Chemistry, Faculty of Pharmacy, Cairo University and Future University in Egypt), Assoc. Professor Ali Mohamed Yehia, (Associate Professor of Analytical Chemistry, Faculty of Pharmacy, Cairo University and University of Hertfordshire Hosted by Global Academic Foundation). |
| 246 15 - VARYING FORM OF TITLE |
| Title proper/short title |
دراسة تحليلة لبعض الادوية المحتوية على مجموعة الكربونيل |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
| Date of publication, distribution, etc |
2021 |
| 300 ## - PHYSICAL DESCRIPTION |
| Extent |
203 pages, 4 pages : |
| Other physical details |
charts (some color) ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
| Source |
rdacontent |
| Content type term |
text |
| 337 ## - MEDIA TYPE |
| Source |
rdamedia |
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
| Source |
rdacarrier |
| Carrier type term |
volume |
| 500 ## - GENERAL NOTE |
| General note |
supervision of Prof. Dr. Samah Sayed Abbas, (Professor and Head of Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University), Prof. Dr. Amr Mohamed Badawey, (Professor of Analytical Chemistry, Faculty of Pharmacy, Cairo University and Future University in Egypt), Assoc. Professor Ali Mohamed Yehia, (Associate Professor of Analytical Chemistry, Faculty of Pharmacy, Cairo University and University of Hertfordshire Hosted by Global Academic Foundation). |
| 502 ## - DISSERTATION NOTE |
| Dissertation note |
Thesis (M.Sc.)-Cairo university, Faculty of pharmacy, Department of Analytical Chemistry, 2021. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
| Bibliography, etc |
Includes bibliographical references. |
| 520 3# - SUMMARY, ETC. |
| Summary, etc |
Renal allograft survival requires multiple immunosuppressive drugs. This strategy<br/>may lead to gastric complications that necessitate gastro-protective medications,<br/>notably, proton pump inhibitors (PPI). This study aimed to compare the influence<br/>of pantoprazole and esomeprazole on serum cyclosporine trough levels (C0) in<br/>renal transplant recipients (RTR). A prospective, parallel, open-label trial was<br/>conducted on 47 adult RTR receiving cyclosporine doses adjusted to attain trough<br/>concentrations of 100 to 150 μg/L, mycophenolate mofetil (MMF) 750 mg<br/>q12 hour and prednisolone at 5 mg daily at Nasser Institute, Cairo, Egypt from<br/>January to September 2016. Patients were randomized into the esomeprazole<br/>group (25) or pantoprazole group (22) receiving the same dose (40 mg once daily).<br/>The study outcomes included clinical signs of rejection and renal function<br/>decline, assessed by elevations in serum creatinine, caused by cyclosporine level<br/>variations in either of the two study groups. Renal function, C0 and CBC measurements were measured at baseline and monthly for 6 months. The mean C0<br/>values were higher in the pantoprazole group than in the esomeprazole group in<br/>the sixth month only (P = .007). Serum creatinine level was lower in the sixth<br/>month than at baseline in the esomeprazole group (P = .004). There were no<br/>signs of rejection biochemical or clinical in any of the study groups. In conclusion,<br/>PPIs should be used with caution and doses should be titrated to reach the C0 targets in RTR, which is of more importance in pantoprazole than esomeprazole to<br/>avoid C0 level elevation or decline affecting the allograft function |
| 546 ## - LANGUAGE NOTE |
| Language note |
Text in English, abstracts in English and Arabic. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Carbonyl compounds |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
| Topical term or geographic name as entry element |
Organic reaction mechanisms |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
| Materials specified |
DSpace electronic resource |
| Uniform Resource Identifier |
<a href="http://repository.fue.edu.eg/xmlui/handle/123456789/5791">http://repository.fue.edu.eg/xmlui/handle/123456789/5791</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
| Koha item type |
Thesis |
| Source of classification or shelving scheme |
Dewey Decimal Classification |